Multiparametric MRI
and Prostate Cancer

Prostate cancer diagnosis is dependent on a number of tests, and Multiparametric MRI is now one of the most important.


Multiparametric MRI provides detailed anatomical and functional information which is unavailable from traditional ultrasound imaging.

Radiologists can use multiparametric MRI to:

  • Identify the location of a tumour
  • Measure the extent of a tumour
  • Estimate the Gleason score of a tumour
  • Determine whether a tumour has spread beyond the prostate gland

What’s special about Multiparametric MRI?

A multiparametric MRI exam consists of three separate imaging techniques (three ‘parameters’) which together give a clear view of the gland.

Multiparametric MRI exams are interpreted according to the Prostate Imaging Reporting and Data System) PI-RADS. This is a classification system that uses a 5-point scale to standardise assessment of exams.

A PI-RADS assessment indicates the likelihood of intermediate – and high-risk cancers based on findings from the three multiparametric MRI sequences.

  1. Very unlikely that clinically significant cancer is present – PI-RADS 1
  2. Unlikely that clinically significant cancer is present – PI-RADS 2 
  3. Uncertain whether clinically significant cancer is present – PI-RADS 3
  4. Likely that clinically significant cancer is present – PI-RADS 4 
  5. Highly likely that clinically significant cancer is present – PI-RADS 5

For results of PI-RADS 4 or 5, prostate biopsy is almost always indicated.

Results of PI-RADS 1 or 2, a recommendation for biopsy is unlikely, but other factors should be considered. PI-RADS 3 results may require a biopsy depending on patient history, local preferences and preferred standard of care.


Advantages of MRI